Latest Regulatory Compliance News

EBR Systems has announced a fully underwritten A$55.9 million capital raise alongside a Security Purchase Plan to fund the commercial rollout of its FDA-approved WiSE CRT System, targeting a US$3.6 billion market opportunity in cardiac resynchronization therapy.

Mayne Pharma has clarified why it did not disclose an FDA Untitled Letter to the market despite sharing it with its scheme bidder, reaffirming compliance with ASX rules amid recent share price volatility.

The Takeovers Panel has issued interim orders compelling Emu NL to submit all proxy forms from its recent extraordinary general meeting, including those disallowed, as part of an ongoing dispute initiated by Wayburn Holdings.

Mayne Pharma has firmly rejected Cosette Pharmaceuticals’ assertion of a Material Adverse Change that could derail their acquisition scheme, insisting the deal process continues as planned.

DMC Mining confirms its exploration permits in Guinea remain unaffected amid a government crackdown on non-compliant mining licences. The company welcomes regulatory reforms aimed at boosting investor confidence and is poised to start exploration once permits are granted.

Infomedia Ltd has responded to an ASX price query following a sharp share price decline and increased trading volume, denying any undisclosed material information. The company pointed to the recent closure of Celeste Funds, a known shareholder, as a potential external factor influencing market activity.

Adriatic Metals has confirmed ongoing discussions with Dundee Precious Metals regarding a possible takeover offer, marking the start of a formal offer period under the UK Takeover Code. While talks continue, no firm offer has yet been made.

Resimac Group Ltd has acknowledged civil penalty proceedings initiated by ASIC against its subsidiary for alleged breaches related to hardship notices, and is proposing a financial contribution program to compensate affected customers.

Webjet Group Limited reports resilient FY25 results following its recent demerger, with a strategic plan to double transaction value by FY30. Despite macroeconomic headwinds, the company maintains strong cash reserves and outlines ambitious growth initiatives.

James Hardie has released its financial results for the fourth quarter and full year ended March 31, 2025, accompanied by a suite of detailed reports filed with both the ASX and SEC.

Sunstone Metals Ltd has had its trading suspension lifted following a Federal Court decision and the release of a cleansing prospectus, signaling a fresh chapter for the mining company on the ASX.

Atomo Diagnostics has released a Target Market Determination for a new capital raising involving options and shares, including a $1 million Share Purchase Plan and placement offer. The move targets eligible Australian shareholders and aims to bolster the company’s financial position amid a speculative investment environment.